Prospective Ascertainment for Late Effects Among Survivors of Cancer, Tumor, or a Related Illness

Memorial Sloan Kettering Cancer Center (MSK)

Status: Completed

Conditions: Pediatric or Young Adult Cancer Survivors

Treatments: Other: Blood sample; Genetic: Salvia sample; Genetic: Family History Questionnaire (FHQ)

Study type: Observational

Funder types: Other

Identifiers

NCT01667952

12-143

Details and patient eligibility

About

The purpose of this study is to establish a registry of survivors of cancer, tumor, or a related illness.

Enrollment: 1,068 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• English speaking
• A personal history of cancer tumor, or a related illness
• Followed in the the Adult Long Term Follow Up Program, Pediatric Long Term Follow Up Program, or Lymphoma Service at MSKCC

Exclusion criteria

• Evidence of active progression of disease or recurrence
• Neurocognitive deficits that impair ability to give informed consent.

Trial design

1,068 participants in 1 patient group

Cancer Survivors

Description:

The purpose of this study is to establish a registry of survivors of cancer, tumors,or a related illness. The registry will include detailed family history and germline DNA. Ultimately, we hope to improve our understanding of genetic susceptibility to secondary malignant neoplasms and other late effects among survivors of cancer, tumors, or a related illness.

Treatment:

Genetic: Family History Questionnaire (FHQ)

Genetic: Salvia sample

Other: Blood sample